Platinum Industries Ltd

Platinum Industries Q3 FY26: Revenue Up 31% YoY, Major Expansions Underway 🚀

- Q3 FY26 standalone revenue: ₹102.62 crores, up 31% year-over-year.

- Nine-month standalone revenue: ₹302.38 crores, up 25% year-over-year.

- Consolidated nine-month revenue: ₹318.42 crores, growing 7.7% year-over-year.

- Q3 EBITDA: ₹16.25 crores with a margin of 15.8%.

- Q3 PAT: ₹12.93 crores, up 18% year-over-year.

- Palghar CPVC plant currently running at 60-65% capacity; full calcium zinc production expected by April 2026.

- Egypt plant commissioning targeted for September 2026.

- Expansion into pharmaceuticals through subsidiary Rivadu LifeSciences (70% owned).

- Expansion into oleo chemicals derivatives via Platinum Oleo Chemicals.

- Targeting over 40% revenue growth in FY27.

- 35% CAGR expected from FY26 to FY29.

- Potential revenue from pharma business expected in FY27.

- Margins moderated due to higher CPVC sales (lower margin product) and capacity expansion costs.

- The company remains net debt-free with a strong balance sheet.